Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker

Heart and Vessels
Eiichi TakiiYoshihiro Fukuomoto

Abstract

Renin-angiotensin system (RAS) inhibitors may be useful in preventing the occurrence of paroxysmal atrial fibrillation (PAF). However, evaluation of such effect is difficult because many PAF episodes are asymptomatic and not all episodes are detected by intermittent electrocardiographic monitoring. A pacemaker has been developed with dedicated functions for AF detection and electrocardiogram storage. Accordingly, we examined the effect of losartan, an angiotensin receptor blocker on PAF occurrence using this new modality. We enrolled 70 consecutive patients who had undergone dual-chamber pacemaker implantation for sick sinus syndrome. Finally, 62 patients participated in the study. Thirty patients were randomized to the losartan group (mean 43 ± 12 mg/day) and 32 patients to the control group. They were followed up for 3 months. The frequency, the maximum duration and the total duration of PAF recorded by the stored electrocardiograms for the last 1 month during the observation period and study period were compared between the two groups. The change in the frequency of PAF from the observation period in the losartan and control groups was similar (-35 ± 25 vs. -67 ± 62 times; NS). However, the change in the maximum duration and...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Apr 29, 1982·The New England Journal of Medicine·W B KannelP M McNamara
Mar 25, 1999·The American Journal of Cardiology·R SuttonA Ingram
Jan 13, 2004·Journal of the American College of Cardiology·Carsten W IsraelStefan H Hohnloser
May 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshiyuki HirayamaTeruo Takano
Jun 7, 2005·Journal of the American College of Cardiology·Jeff S HealeyStuart J Connolly
Nov 16, 2005·Journal of the American College of Cardiology·Alessandro CapucciUNKNOWN Italian AT500 Registry Investigators
Nov 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Hideko Nakashima, Koichiro Kumagai
Jan 15, 2009·Pacing and Clinical Electrophysiology : PACE·Gianluca QuirinoS Serge Barold
Apr 17, 2009·The New England Journal of Medicine·Marcello DisertoriGianni Tognoni
May 22, 2010·Journal of the American College of Cardiology·Markus P SchneiderRoland E Schmieder
Mar 11, 2011·The New England Journal of Medicine·UNKNOWN ACTIVE I InvestigatorsStuart J Connolly
Dec 14, 2011·Circulation. Arrhythmia and Electrophysiology·Andreas GoetteThomas Meinertz
Apr 28, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jagmeet P SinghNiteesh K Choudhry

❮ Previous
Next ❯

Citations

Mar 5, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Csaba András Dézsi
Jan 17, 2017·Scandinavian Journal of Medicine & Science in Sports·A MüssigbrodtG Hindricks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.